Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
acetaminophen, advisory, affirmed, allocate, analgesic, arthroplasty, ASC, billing, bore, Breakthrough, byTerSera, carryforward, certiorari, Circuit, CMS, coat, cohort, condensed, conservative, correlation, cyber, disgorgement, double, dual, efficacyin, entrance, faster, formal, healing, hierarchical, ibuprofen, inflammation, ingredient, invoice, knee, linked, mammoplasty, medial, Mexico, milligram, MINE, MME, morphine, owner, parallel, pectoral, pocket, posterior, prodrug, provisional, reconciliation, refined, repayment, rest, SAB, shut, strong, sublease, SUPPLEMENTARY, Supreme, suturing, syringe, theAUC, thereto, triple, twelve, uncollectible, unilateral, UNRESOLVED, UpdateNo
Filing tables
Filing exhibits
Related press release
HRTX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos.333-219172,333-195928 and333-212784) and FormS-8 (Nos.333-219830,333-35151,333-90428,333-118546,333-127574,333-137954,333-148660,333-162610,333-167515,333-176365,333-176366,333-190549,333-198853,333-202588,333-206165 and333-214503) of Heron Therapeutics, Inc. of our reports dated February 22, 2019 relating to the consolidated financial statements and the effectiveness of Heron Therapeutics, Inc.’s internal control over financial reporting, which appear in this Annual Report on Form10-K.
/s/ OUM & CO. LLP |
San Francisco, California |
February 22, 2019 |